小児臨床試験の世界市場レポート 2025年

小児臨床試験市場規模は、今後数年間で力強い成長が見込まれます。2029年には248億米ドルに成長し、CAGRは7.7%となります。予測期間の成長は、実世界のエビデンスの統合、小児バイオマーカーの発見、拡大アクセスプログラム、小児感染症調査、小児循環器学の進歩に起因すると考えられます。予測期間における世界の動向には、患者中心の試験デザイン、適応型試験デザインの採用、デジタルヘルス技術、国際共同研究およびコンソーシアム、小児腫瘍学の進歩などが含まれます。

小児がん患者の増加は、小児臨床試験市場を前進させると予想されます。小児がんはまれではあるが、成人の腫瘍とは異なる独特の成長パターンを示すため、専門的な調査や治療が必要となります。小児臨床試験は、予後や治療法を進歩させる上で極めて重要な役割を果たしています。米国がん協会の2023年1月の推計によると、米国では15歳未満の小児が約9,910人がんと診断され、2023年には約1,040人が死亡すると予想されています。その結果、ヘルスケア支出の増加が小児臨床試験市場の成長を促進します。

アウトソーシングサービスに対する需要の急増が、小児臨床試験市場の拡大を後押しします。前臨床研究が複雑化するにつれて、製薬会社やバイオテクノロジー会社は社内の能力を超えた専門スキルを求めるようになってきています。アウトソーシングサービスは、安全で倫理的、科学的に強固な小児臨床試験プロトコルの作成を支援します。BioPlan Associates Inc.が2023年4月に実施した調査では、バイオメーカーの約84.6%が分析試験をアウトソーシングしており、74.5%が毒性試験のアウトソーシングを求めていることが明らかになった。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界小児臨床試験PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の小児臨床試験市場：成長率分析
• 世界の小児臨床試験市場の実績：規模と成長, 2019-2024
• 世界の小児臨床試験市場の予測：規模と成長, 2024-2029, 2034F
• 世界小児臨床試験総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の小児臨床試験市場フェーズ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• フェーズI
• フェーズII
• フェーズIII
• フェーズIV
• 世界の小児臨床試験市場研究デザインによる、実績と予測, 2019-2024, 2024-2029F, 2034F
• 治療研究
• 観察研究
• 世界の小児臨床試験市場治療領域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 感染症
• 腫瘍学
• 自己免疫疾患または炎症性疾患
• 呼吸器疾患
• 精神疾患
• その他の治療領域
• 世界の小児臨床試験市場、フェーズIのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 小児科における初めての試験
• 用量漸増研究
• 安全性と忍容性の評価
• 世界の小児臨床試験市場、フェーズ IIのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 有効性研究
• 用量最適化試験
• 薬物動態研究
• 世界の小児臨床試験市場、フェーズIIIのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 大規模有効性試験
• 比較研究
• 長期安全性研究
• 世界の小児臨床試験市場、フェーズIVのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 市販後調査
• 長期安全性モニタリング
• 実世界における有効性研究

第7章 地域別・国別分析

• 世界の小児臨床試験市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の小児臨床試験市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 小児臨床試験市場：競合情勢
• 小児臨床試験市場：企業プロファイル
  • Medpac Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Pharmaceutical Product Development Inc. Overview, Products and Services, Strategy and Financial Analysis
  • ICON plc Overview, Products and Services, Strategy and Financial Analysis
  • Syneos Health Inc. Overview, Products and Services, Strategy and Financial Analysis
  • QPS Holdings LLC Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Pfizer Inc.
• IQVIA Inc.
• Premier Research
• Labcorp-Laboratory Corporation of America Holdings
• The Emmes Company LLC
• Synteract Inc.
• Charles River Laboratories International Inc.
• Covance Inc.
• Bristol-Myers Squibb Company
• GlaxoSmithKline plc
• BioNTech SE
• Moderna Inc.
• Parexel International Corporation
• PRA Health Sciences
• Wuxi AppTec

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 小児臨床試験市場2029：新たな機会を提供する国
• 小児臨床試験市場2029：新たな機会を提供するセグメント
• 小児臨床試験市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Pediatric clinical trials serve as critical investigations into the efficacy, safety, and appropriate dosage of pharmaceuticals, medical devices, and therapies specifically tailored for children. Developing age-appropriate treatments and procedures is paramount in refining and identifying the most effective medical interventions available for pediatric patients.

These trials typically encompass several distinct phases Phase I, Phase II, Phase III, and Phase IV. Phase I trials primarily concentrate on establishing the safety profile and determining the appropriate dosage range of new medications, typically involving 20-100 healthy volunteers. Diverse study designs, such as treatment and observational studies, are employed across various therapeutic areas. These encompass infectious diseases, oncology, autoimmune or inflammatory diseases, respiratory disorders, mental health disorders, among other medical domains, enabling comprehensive exploration and assessment of treatments for pediatric patients.

The pediatric clinical trials market research report is one of a series of new reports from The Business Research Company that provides pediatric clinical trials market statistics, including pediatric clinical trials industry global market size, regional shares, competitors with a pediatric clinical trials market share, detailed pediatric clinical trials market segments, market trends and opportunities, and any further data you may need to thrive in the pediatric clinical trials industry. This pediatric clinical trials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pediatric clinical trials market size has grown strongly in recent years. It will grow from$17.41 billion in 2024 to $18.45 billion in 2025 at a compound annual growth rate (CAGR) of 6.0%. The growth in the historic period can be attributed to regulatory incentives, unmet medical needs, advancements in pediatric medicine, global public health initiatives, ethical imperatives, pediatric vaccination programs

The pediatric clinical trials market size is expected to see strong growth in the next few years. It will grow to $24.8 billion in 2029 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to integration of real-world evidence, pediatric biomarker discovery, expanded access programs, pediatric infectious disease research, pediatric cardiology advancements. Major trends in the forecast period include patient-centric trial design, adoption of adaptive trial designs, digital health technologies, global collaboration and consortia, pediatric oncology advancements.

The rise in pediatric cancer cases is expected to drive the pediatric clinical trials market forward. Pediatric cancers, though rare, exhibit unique growth patterns distinct from adult tumors, necessitating specialized research and treatments. Pediatric clinical trials play a pivotal role in advancing prognosis and treatment methods. According to the American Cancer Society's estimates in January 2023, approximately 9,910 children in the US under 15 will be diagnosed with cancer, with about 1,040 expected deaths in 2023. Consequently, increased healthcare spending fuels the growth of the pediatric clinical trials market.

The burgeoning demand for outsourcing services is set to propel the pediatric clinical trials market's expansion. As preclinical research grows in complexity, pharmaceutical and biotech companies increasingly seek specialized skills beyond their in-house capabilities. Outsourcing services aid in crafting safe, ethical, and scientifically robust pediatric clinical trial protocols. A survey by BioPlan Associates Inc. in April 2023 revealed that around 84.6% of biomanufacturers outsource analytical testing, while 74.5% seek toxicity testing outsourcing, highlighting the surging reliance on outsourcing in pediatric clinical trials, driving market growth.

Product innovation stands out as a pivotal trend reshaping the pediatric clinical trial market. Companies within this sector are investing in innovative products to maintain their market standing. An instance is The Leukemia & Lymphoma Society's launch of the Pediatric Acute Leukemia (PedAL) Master Clinical Trial in June 2022. This groundbreaking trial is tailored to pediatric acute leukemia, leveraging individual tumor biology to match children with the most promising treatments, emphasizing innovation in pediatric cancer research.

Major players in pediatric clinical trials prioritize collaborations and partnerships to deliver dependable services. Strategic partnerships, characterized by structured affiliations between commercial entities, are pivotal in fostering reliability in service provision. Strados Labs' collaboration with Ann & Robert H. Lurie Children's Hospital in September 2023 exemplifies this approach. Their clinical trial involves the RESP Biosensor, a wearable device employing acoustic sensors to monitor lung sounds for asthma symptoms. The trial aims to assess the RESP Biosensor's effectiveness in accurately detecting and monitoring asthma exacerbations in children, showcasing partnerships' role in advancing pediatric healthcare technology.

In March 2024, PCM Trials, a U.S.-based provider of mobile research nurse visits for decentralized clinical trials, acquired EmVenio Research for an undisclosed amount. This acquisition enables PCM Trials to adopt a more patient-centric and decentralized approach to clinical trials, enhancing participant recruitment and retention, especially among underrepresented minorities. EmVenio is a U.S.-based company focused on improving access to pediatric clinical trials, particularly for diverse and underserved populations.

Major companies operating in the pediatric clinical trials market include Medpac Inc., Pharmaceutical Product Development Inc., ICON plc, Syneos Health Inc., QPS Holdings LLC, Pfizer Inc., IQVIA Inc., Premier Research, Labcorp - Laboratory Corporation of America Holdings, The Emmes Company LLC, Synteract Inc., Charles River Laboratories International Inc., Covance Inc., Bristol-Myers Squibb Company, GlaxoSmithKline plc, BioNTech SE, Moderna Inc., Parexel International Corporation, PRA Health Sciences, Wuxi AppTec, Merck & Co. Inc., AstraZeneca plc, Sanofi S.A., Johnson & Johnson, Eli Lilly and Company, Takeda Pharmaceutical Company Limited, C.H. Boehringer Sohn AG & Co. KG, AbbVie Inc., Teva Pharmaceutical Industries Ltd., Oracle Health sciences

North America was the largest region in the pediatric clinical trials market in 2024. The regions covered in the pediatric clinical trials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the pediatric clinical trials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The pediatric clinical trials market includes revenues earned by entities through clinical research services, consulting, outsourcing services, and medical communications. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pediatric Clinical Trials Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pediatric clinical trials market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pediatric clinical trials ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pediatric clinical trials market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Phase: Phase I; Phase II; Phase III; Phase IV
• 2) By Study Design: Treatment Studies; Observational Studies
• 3) By Therapeutic Areas: Infectious Diseases; Oncology; Autoimmune Or Inflammatory Diseases; Respiratory Disorders; Mental Health Disorders; Other Therapeutic Areas
• Subsegments:
• 1) By Phase I: First-in-Pediatrics Trials; Dose Escalation Studies; Safety And Tolerability Assessments
• 2) By Phase II: Efficacy Studies; Dose Optimization Trials; Pharmacokinetic Studies
• 3) By Phase III: Large-Scale Efficacy Trials; Comparative Studies; Long-Term Safety Studies
• 4) By Phase IV: Post-Marketing Surveillance; Long-Term Safety Monitoring; Effectiveness Studies In Real-World Settings
• Companies Mentioned: Medpac Inc.; Pharmaceutical Product Development Inc.; ICON plc; Syneos Health Inc.; QPS Holdings LLC
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pediatric Clinical Trials Market Characteristics

3. Pediatric Clinical Trials Market Trends And Strategies

4. Pediatric Clinical Trials Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Pediatric Clinical Trials Growth Analysis And Strategic Analysis Framework

• 5.1. Global Pediatric Clinical Trials PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Pediatric Clinical Trials Market Growth Rate Analysis
• 5.4. Global Pediatric Clinical Trials Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Pediatric Clinical Trials Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Pediatric Clinical Trials Total Addressable Market (TAM)

6. Pediatric Clinical Trials Market Segmentation

• 6.1. Global Pediatric Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Phase I
• Phase II
• Phase III
• Phase IV
• 6.2. Global Pediatric Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Treatment Studies
• Observational Studies
• 6.3. Global Pediatric Clinical Trials Market, Segmentation By Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Infectious Diseases
• Oncology
• Autoimmune Or Inflammatory Diseases
• Respiratory Disorders
• Mental Health Disorders
• Other Therapeutic Areas
• 6.4. Global Pediatric Clinical Trials Market, Sub-Segmentation Of Phase I, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• First-in-Pediatrics Trials
• Dose Escalation Studies
• Safety And Tolerability Assessments
• 6.5. Global Pediatric Clinical Trials Market, Sub-Segmentation Of Phase II, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Efficacy Studies
• Dose Optimization Trials
• Pharmacokinetic Studies
• 6.6. Global Pediatric Clinical Trials Market, Sub-Segmentation Of Phase III, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Large-Scale Efficacy Trials
• Comparative Studies
• Long-Term Safety Studies
• 6.7. Global Pediatric Clinical Trials Market, Sub-Segmentation Of Phase IV, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Post-Marketing Surveillance
• Long-Term Safety Monitoring
• Effectiveness Studies In Real-World Settings

7. Pediatric Clinical Trials Market Regional And Country Analysis

• 7.1. Global Pediatric Clinical Trials Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Pediatric Clinical Trials Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pediatric Clinical Trials Market

• 8.1. Asia-Pacific Pediatric Clinical Trials Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Pediatric Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Pediatric Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Pediatric Clinical Trials Market, Segmentation By Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pediatric Clinical Trials Market

• 9.1. China Pediatric Clinical Trials Market Overview
• 9.2. China Pediatric Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Pediatric Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Pediatric Clinical Trials Market, Segmentation By Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pediatric Clinical Trials Market

• 10.1. India Pediatric Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Pediatric Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Pediatric Clinical Trials Market, Segmentation By Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pediatric Clinical Trials Market

• 11.1. Japan Pediatric Clinical Trials Market Overview
• 11.2. Japan Pediatric Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Pediatric Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Pediatric Clinical Trials Market, Segmentation By Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pediatric Clinical Trials Market

• 12.1. Australia Pediatric Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Pediatric Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Pediatric Clinical Trials Market, Segmentation By Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pediatric Clinical Trials Market

• 13.1. Indonesia Pediatric Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Pediatric Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Pediatric Clinical Trials Market, Segmentation By Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pediatric Clinical Trials Market

• 14.1. South Korea Pediatric Clinical Trials Market Overview
• 14.2. South Korea Pediatric Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Pediatric Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Pediatric Clinical Trials Market, Segmentation By Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pediatric Clinical Trials Market

• 15.1. Western Europe Pediatric Clinical Trials Market Overview
• 15.2. Western Europe Pediatric Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Pediatric Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Pediatric Clinical Trials Market, Segmentation By Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pediatric Clinical Trials Market

• 16.1. UK Pediatric Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Pediatric Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Pediatric Clinical Trials Market, Segmentation By Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pediatric Clinical Trials Market

• 17.1. Germany Pediatric Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Pediatric Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Pediatric Clinical Trials Market, Segmentation By Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pediatric Clinical Trials Market

• 18.1. France Pediatric Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Pediatric Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Pediatric Clinical Trials Market, Segmentation By Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pediatric Clinical Trials Market

• 19.1. Italy Pediatric Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Pediatric Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Pediatric Clinical Trials Market, Segmentation By Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pediatric Clinical Trials Market

• 20.1. Spain Pediatric Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Pediatric Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Pediatric Clinical Trials Market, Segmentation By Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pediatric Clinical Trials Market

• 21.1. Eastern Europe Pediatric Clinical Trials Market Overview
• 21.2. Eastern Europe Pediatric Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Pediatric Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Pediatric Clinical Trials Market, Segmentation By Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pediatric Clinical Trials Market

• 22.1. Russia Pediatric Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Pediatric Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Pediatric Clinical Trials Market, Segmentation By Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pediatric Clinical Trials Market

• 23.1. North America Pediatric Clinical Trials Market Overview
• 23.2. North America Pediatric Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Pediatric Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Pediatric Clinical Trials Market, Segmentation By Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pediatric Clinical Trials Market

• 24.1. USA Pediatric Clinical Trials Market Overview
• 24.2. USA Pediatric Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Pediatric Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Pediatric Clinical Trials Market, Segmentation By Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pediatric Clinical Trials Market

• 25.1. Canada Pediatric Clinical Trials Market Overview
• 25.2. Canada Pediatric Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Pediatric Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Pediatric Clinical Trials Market, Segmentation By Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pediatric Clinical Trials Market

• 26.1. South America Pediatric Clinical Trials Market Overview
• 26.2. South America Pediatric Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Pediatric Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Pediatric Clinical Trials Market, Segmentation By Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pediatric Clinical Trials Market

• 27.1. Brazil Pediatric Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Pediatric Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Pediatric Clinical Trials Market, Segmentation By Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pediatric Clinical Trials Market

• 28.1. Middle East Pediatric Clinical Trials Market Overview
• 28.2. Middle East Pediatric Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Pediatric Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Pediatric Clinical Trials Market, Segmentation By Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pediatric Clinical Trials Market

• 29.1. Africa Pediatric Clinical Trials Market Overview
• 29.2. Africa Pediatric Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Pediatric Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Pediatric Clinical Trials Market, Segmentation By Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pediatric Clinical Trials Market Competitive Landscape And Company Profiles

• 30.1. Pediatric Clinical Trials Market Competitive Landscape
• 30.2. Pediatric Clinical Trials Market Company Profiles
  • 30.2.1. Medpac Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Pharmaceutical Product Development Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. ICON plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Syneos Health Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. QPS Holdings LLC Overview, Products and Services, Strategy and Financial Analysis

31. Pediatric Clinical Trials Market Other Major And Innovative Companies

• 31.1. Pfizer Inc.
• 31.2. IQVIA Inc.
• 31.3. Premier Research
• 31.4. Labcorp - Laboratory Corporation of America Holdings
• 31.5. The Emmes Company LLC
• 31.6. Synteract Inc.
• 31.7. Charles River Laboratories International Inc.
• 31.8. Covance Inc.
• 31.9. Bristol-Myers Squibb Company
• 31.10. GlaxoSmithKline plc
• 31.11. BioNTech SE
• 31.12. Moderna Inc.
• 31.13. Parexel International Corporation
• 31.14. PRA Health Sciences
• 31.15. Wuxi AppTec

32. Global Pediatric Clinical Trials Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pediatric Clinical Trials Market

34. Recent Developments In The Pediatric Clinical Trials Market

35. Pediatric Clinical Trials Market High Potential Countries, Segments and Strategies

• 35.1 Pediatric Clinical Trials Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Pediatric Clinical Trials Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Pediatric Clinical Trials Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer